PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY

Abstract

Chronic non-communicable disorder of the brain epilepsy is one of the most common neurological diseases in the world and characterized by repeated attacks with a variety of clinical manifestations. Epilepsy has significant economic consequences in terms of meeting health care needs, premature mortality and lost ability to work. Epilepsy requires long-term therapy, which plays a crucial role in the patient’s recovery and makes a tangible contribution to the quality of life. In this respect, one of the most studied choices in different variants of both partial and generalized forms of epilepsy is valproates. The article provides an economic assessment of the use of the tablet form of the most common valproic acid drugs, as well as the possible minimization of costs (budget savings) in the transition to the most economically advantageous option of therapy.

Keywords

• epilepsy
• monotherapy
• valproates
• valproic acid
• convuleks